Biogen Idec (BIIB)

Add to Watchlists
Create an Alert
285.49 +5.97  +2.14% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD

Biogen Idec Revenue (Quarterly):

1.966B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Biogen Idec Revenue (Quarterly) Chart

Pro Export Data
Pro Save Image

Biogen Idec Historical Revenue (Quarterly) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 1.966B
Sept. 30, 2013 1.828B
June 30, 2013 1.723B
March 31, 2013 1.415B
Dec. 31, 2012 1.418B
Sept. 30, 2012 1.386B
June 30, 2012 1.421B
March 31, 2012 1.292B
Dec. 31, 2011 1.327B
Sept. 30, 2011 1.310B
June 30, 2011 1.209B
March 31, 2011 1.203B
Dec. 31, 2010 1.219B
Sept. 30, 2010 1.176B
June 30, 2010 1.213B
March 31, 2010 1.109B
Dec. 31, 2009 1.127B
Sept. 30, 2009 1.121B
June 30, 2009 1.093B
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
March 31, 2008 Go Pro
Dec. 31, 2003 Go Pro
   
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro
Sept. 30, 2002 Go Pro
June 30, 2002 Go Pro
March 31, 2002 Go Pro
Dec. 31, 2001 Go Pro
Sept. 30, 2001 Go Pro
June 30, 2001 Go Pro
March 31, 2001 Go Pro
Dec. 31, 2000 Go Pro
Sept. 30, 2000 Go Pro
June 30, 2000 Go Pro
March 31, 2000 Go Pro
Dec. 31, 1999 Go Pro
Sept. 30, 1999 Go Pro
June 30, 1999 Go Pro
March 31, 1999 Go Pro
Dec. 31, 1998 Go Pro
Sept. 30, 1998 Go Pro
June 30, 1998 Go Pro
March 31, 1998 Go Pro
Dec. 31, 1997 Go Pro
Sept. 30, 1997 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Get data for
Advertisement

BIIB Revenue (Quarterly) Benchmarks

Companies
Gilead Sciences 3.120B
Novartis 15.36B
Celgene 1.756B

BIIB Revenue (Quarterly) Range, Past 5 Years

Minimum 1.093B Jun 2009
Maximum 1.966B Dec 2013
Average 1.345B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.